Aidigong Maternal & Child Health Limited (HKG:0286)
Hong Kong · Delayed Price · Currency is HKD 1.310
-0.010 (-0.76%)
At close: Feb 21, 2025
HKG:0286 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| 522.09 | 554.58 | 679.95 | 642.57 | 601.21 | 610.61 | |
Revenue Growth (YoY) | -20.70% | -18.44% | 5.82% | 6.88% | -1.54% | 61.95% |
Cost of Revenue | 424.06 | 433.55 | 581.21 | 437.16 | 355.08 | 419.03 |
Gross Profit | 98.03 | 121.03 | 98.74 | 205.41 | 246.13 | 191.58 |
Selling, General & Admin | 260.59 | 257.19 | 269.48 | 170.9 | 170.88 | 122.93 |
Other Operating Expenses | -13.67 | -15.28 | -15.54 | -12.39 | -13.67 | -4.47 |
Operating Expenses | 246.92 | 241.9 | 253.94 | 158.51 | 157.21 | 118.46 |
Operating Income | -148.89 | -120.87 | -155.2 | 46.91 | 88.92 | 73.12 |
Interest Expense | -45.89 | -53.77 | -64.57 | -65.67 | -64.72 | -44.81 |
Interest & Investment Income | 9.87 | 9.83 | 7.87 | 8.27 | 5.48 | 4.11 |
Earnings From Equity Investments | 0.31 | 0.31 | -0.25 | -0.8 | 4.31 | 8.35 |
EBT Excluding Unusual Items | -184.6 | -164.51 | -212.15 | -11.3 | 33.99 | 40.77 |
Merger & Restructuring Charges | - | - | - | - | - | -4.06 |
Impairment of Goodwill | - | - | - | - | -229.01 | - |
Gain (Loss) on Sale of Investments | 0.13 | 0.13 | 0.23 | 7.04 | -87.03 | 4.22 |
Gain (Loss) on Sale of Assets | -0.75 | -0.75 | 4.79 | 55.16 | 5.9 | - |
Asset Writedown | - | - | - | - | -78.05 | - |
Other Unusual Items | 0.17 | 1.36 | 7.84 | 2.51 | -9.68 | -4.81 |
Pretax Income | -185.05 | -163.77 | -199.28 | 53.41 | -363.88 | 36.13 |
Income Tax Expense | 8.22 | 13.08 | -21.14 | 18.62 | 18.76 | 19.04 |
Earnings From Continuing Operations | -193.28 | -176.85 | -178.14 | 34.79 | -382.64 | 17.09 |
Net Income to Company | -193.28 | -176.85 | -178.14 | 34.79 | -382.64 | 17.09 |
Minority Interest in Earnings | 0.32 | -0.57 | 12.82 | -29.49 | 1.29 | -5.85 |
Net Income | -192.96 | -177.42 | -165.32 | 5.3 | -381.35 | 11.24 |
Net Income to Common | -192.96 | -177.42 | -165.32 | 5.3 | -381.35 | 11.24 |
Net Income Growth | - | - | - | - | - | 420.23% |
Shares Outstanding (Basic) | 115 | 109 | 108 | 102 | 96 | 80 |
Shares Outstanding (Diluted) | 115 | 109 | 108 | 102 | 96 | 80 |
Shares Change (YoY) | 5.77% | 0.97% | 5.97% | 6.15% | 19.33% | 7.13% |
EPS (Basic) | -1.68 | -1.63 | -1.53 | 0.05 | -3.98 | 0.14 |
EPS (Diluted) | -1.68 | -1.63 | -1.54 | 0.05 | -3.98 | 0.14 |
EPS Growth | - | - | - | - | - | 400.00% |
Free Cash Flow | 34.14 | 46.35 | 79.65 | 81.74 | -41.64 | -16.89 |
Free Cash Flow Per Share | 0.30 | 0.43 | 0.74 | 0.80 | -0.43 | -0.21 |
Dividend Per Share | - | - | - | - | - | 0.027 |
Gross Margin | 18.78% | 21.82% | 14.52% | 31.97% | 40.94% | 31.37% |
Operating Margin | -28.52% | -21.80% | -22.82% | 7.30% | 14.79% | 11.97% |
Profit Margin | -36.96% | -31.99% | -24.31% | 0.83% | -63.43% | 1.84% |
Free Cash Flow Margin | 6.54% | 8.36% | 11.71% | 12.72% | -6.93% | -2.77% |
EBITDA | -103.46 | -73.1 | -101.43 | 96.2 | 138.06 | 97.72 |
EBITDA Margin | -19.82% | -13.18% | -14.92% | 14.97% | 22.96% | 16.00% |
D&A For EBITDA | 45.43 | 47.77 | 53.76 | 49.29 | 49.14 | 24.61 |
EBIT | -148.89 | -120.87 | -155.2 | 46.91 | 88.92 | 73.12 |
EBIT Margin | -28.52% | -21.80% | -22.82% | 7.30% | 14.79% | 11.97% |
Effective Tax Rate | - | - | - | 34.87% | - | 52.70% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.